The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank Ling et al.|Cancer Discovery|2020Cited by 26
Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK InhibitorsClare F. Malone, Kimberly Stegmaier, Minjee Kim et al.|Cancer Research|2022Cited by 17
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank Ling et al.|Blood|2019Cited by 5
Supplementary Table S1 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK InhibitorsClare F. Malone, Kimberly Stegmaier, Minjee Kim et al.|Unknown|2023Cited by 0
Supplementary Table S2 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK InhibitorsClare F. Malone, Kimberly Stegmaier, Minjee Kim et al.|Unknown|2023Cited by 0